$IEX

IDEX CORP /DE/ (IEX): Results of Operations and Financial Condition

IDEX CORP /DE/ (IEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 iex-20260630xex991.htm EX-99.1 Document For further information: TRADED: NYSE (IEX) EX-99.1 Investor Contact: Jim Giannakouros, CFA Vice President, Investor Relations (847) 313-9506 IDEX REPORTS SECOND QUARTER RESULTS Highlights (All comparisons are against the prior ye

Original reporting
Published Jul 29, 2026, 11:01 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 11:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$IEX
Bullish
high confidence
Mentioned
$IEX
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$IEXBullishHigh
01

Why it matters

Record orders and sales growth, higher diluted and adjusted EPS, and raised full-year organic sales and adjusted EPS ranges are the key decision inputs for positioning into 2H 2026.

02

Market read

This is a primary earnings and guidance release with specific raised ranges, plus quantified contributions from tariff refund dynamics and segment drivers.

03

What to watch

Organic sales growth was impacted by expected customer rebates tied to IEEPA tariff refunds (unfavorably impacting organic growth by 2%), so traders should watch whether that headwind reverses or persists in 2H.

Relevance 7/10Novelty 9/10Timing: filed pre-market today with raised full-year 2026 guidance ranges

Background

The 8-K (Item 2.02) includes IDEX’s Q2 2026 financial results and a guidance update, with discussion of IEEPA tariff refund effects and segment performance.

Company-level read

Ticker impact

$IEXBullishHigh confidence
Context

IDEX reports Q2 results with record sales of $921M, record orders above $1B, and raises full-year organic growth and adjusted EPS guidance.

Expected impact

Likely positive near-term bias as traders reprice 2026 organic growth and adjusted EPS expectations.

Evidence & confidence

The filing is a primary earnings and guidance update (8-K with EX-99.1) including specific raised ranges for full-year organic sales and adjusted diluted EPS, alongside record orders and EPS beats.

Market effects

Supports read-across for industrial instrumentation and process technologies demand, especially where data center power and semiconductor-related capex drive volumes.

Limited direct regional impact; primarily US-listed company-specific guidance.

IEEPA tariff refund dynamics and international customer rebates highlight cross-border policy sensitivity for industrial suppliers.

Counterpoint

The guidance raise may be partially driven by tariff refund benefits and favorable price/cost, which could normalize in later quarters.

Key entities

  • IDEX Corporation

    NYSE-listed industrial technology company reporting Q2 2026 results and raising full-year 2026 organic growth and adjusted EPS guidance.

  • IEEPA tariff refunds

    Tariff-related refunds and customer rebates under the International Emergency Economic Powers Act that affected reported and organic growth, margins, and cash flows.

Related articles

$IEXHighAI 9/10

IDEX (IEX) Q2 2026 Earnings Call Transcript

IDEX (IEX) Q2 2026 earnings call reported organic revenue growth of 5% and organic orders up 28%. HST led with 47% organic order growth and 12% organic revenue growth. Adjusted EPS was $2.32, above guidance $2.07 to $2.12, and adjusted EBITDA margin rose 70 bps. Free cash flow was $177M, liquidity over $1.1B, and $77M share repurchases. IEEPA tariff refunds added a $0.08 EPS benefit.

$IEXMed

IEX's plea against power exchange market coupling rejected by SC

India’s Supreme Court rejected Indian Energy Exchange (IEX)’s plea to stop CERC’s market coupling regulations for power exchanges, saying it was not the right stage because the rules are not yet finalized. The Court allowed CERC to continue drafting while noting it expressed no view on merits. IEX argued coupling would reduce competition and raised conflict-of-interest concerns.

$IEXHighAI 9/10

IDEX Raises Full-Year Outlook After Strong Second-Quarter Results

IDEX Corporation (NYSE:IEX) reported better-than-expected second-quarter earnings and revenue while raising its full-year guidance, sending the industrial technology company's shares nearly 4% higher in premarket trading on Wednesday. Adjusted earnings came in at $2.32 per share for the quarter ended June 30, exceeding the Wall Street consensus estimate of $2.11 by $0.21.

$IEXMedAI 8/10

IDEX Pops on Quarterly Figures

IDEX Corporation (NYSE: IEX) reported quarterly results for the three months ended June 30, 2026. The company said orders exceeded $1 billion, a record, and projected Q3 2026 organic sales growth of 5% to 7% and adjusted diluted EPS of $2.20 to $2.25. Net sales included a $14.7 million reduction from customer rebates tied to invalidated tariff refunds, and IDEX raised full-year guidance.

$IEXMedAI 8/10

IDEX Boosts FY26 Outlook; Shares Up 7% - Update

IDEX Corp. (IEX) reported Q2 results and raised its FY2026 outlook. For Q3, it guided adjusted EPS of $2.20 to $2.25 and organic net sales growth of about 5% to 7%. For FY2026, it now expects adjusted EPS of $8.70 to $8.85 with organic growth of 3% to 4%, versus prior $8.35 to $8.55. Shares were up about 7% premarket.